MedImmune gets patent for MDCK cell line to speed flu vaccine production
AstraZeneca’s biologics wing MedIummune has been granted a US patent for an optimised cell line used to make infleunza vaccine.
Archives for October 6, 2014
Baxter Transitions Biopharma R&D to a New Hub in Cambridge
Baxter International plans to set up a new global R&D center in Cambridge, Mass, for Baxalta, its biopharmaceuticals spinoff, which is expected be formally incorporated next year and headquartered in northern Illinois.